Micheal Sandbank is assistant professor of special education at the University of Texas at Austin.
Micheal Sandbank
Assistant professor
University of Texas at Austin
From this contributor
By
Kristen Bottema-Beutel, Shannon Crowley, Micheal Sandbank, Tiffany Woynaroski
24 November 2020
7 min read
Errors of omission: Why we are deeply concerned about research on autism therapies
Studies of autism treatments rarely report adverse events, and the scientists involved often fail to disclose their conflicts of interest.
Errors of omission: Why we are deeply concerned about research on autism therapies
By
Kristen Bottema-Beutel, Shannon Crowley, Micheal Sandbank, Tiffany Woynaroski
24 November 2020 | 7 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read